Skip to menu Skip to content Skip to footer
Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Overview

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Works

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025

141 - 160 of 376 works

2021

Journal Article

Medicinal psychedelics for mental health and addiction: advancing research of an emerging paradigm

Perkins, Daniel, Sarris, Jerome, Rossell, Susan, Bonomo, Yvonne, Forbes, David, Davey, Christopher, Hoyer, Daniel, Loo, Colleen, Murray, Greg, Hood, Sean, Schubert, Violeta, Galvão-Coelho, Nicole Leite, O’Donnell, Meaghen, Carter, Olivia, Liknaitzky, Paul, Williams, Martin, Siskind, Dan, Penington, David, Berk, Michael and Castle, David (2021). Medicinal psychedelics for mental health and addiction: advancing research of an emerging paradigm. Australian and New Zealand Journal of Psychiatry, 55 (12) 0004867421998785, 4867421998785-1133. doi: 10.1177/0004867421998785

Medicinal psychedelics for mental health and addiction: advancing research of an emerging paradigm

2020

Journal Article

Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness A Public Health Priority

Warren, Nicola, Kisely, Steve and Siskind, Dan (2020). Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness A Public Health Priority. JAMA Psychiatry, 78 (6), 589-590. doi: 10.1001/jamapsychiatry.2020.4396

Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness A Public Health Priority

2020

Journal Article

Appraisal of physical health guidelines for severe mental illness

Friend, Nadia, Hughes, Jade, Kisely, Steve, Kumar, Ratika and Siskind, Dan (2020). Appraisal of physical health guidelines for severe mental illness. Australian Health Review, 44 (6), 904-915. doi: 10.1071/AH20080

Appraisal of physical health guidelines for severe mental illness

2020

Conference Publication

Can monitoring clozapine and norclozapine levels reduce the occurrence of peripheral ADRs?

Tan, Madeleine S. A., Honarparvar, Faraz , Falconer, James R., Parekh, Harendra S., Pandey, Preeti and Siskind, Dan J. (2020). Can monitoring clozapine and norclozapine levels reduce the occurrence of peripheral ADRs?. ASCEPT-APSA Joint Virtual Scientific Meeting, Hamilton Central, QLD, Australia, 24-26 November 2020.

Can monitoring clozapine and norclozapine levels reduce the occurrence of peripheral ADRs?

2020

Conference Publication

Therapeutic drug monitoring as a tool for clozapine therapy in minimising peripheral ADRs

Tan, Madeleine , Honarparvar, Faraz , Falconer, James , Parekh, Harendra , Pandey, Preeti and Siskind, Dan (2020). Therapeutic drug monitoring as a tool for clozapine therapy in minimising peripheral ADRs. Australian Society for Medical Research (ASMR) Queensland Post Graduate Students Virtual Scientific Symposium, Sydney, NSW Australia, 10-11 November 2020.

Therapeutic drug monitoring as a tool for clozapine therapy in minimising peripheral ADRs

2020

Journal Article

Clozapine Combination and Augmentation Strategies in Patients with Schizophrenia - Recommendations from an International Expert Survey among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group

Wagner, Elias, Kane, John M., Correll, Christoph U., Howes, Oliver, Siskind, Dan, Honer, William G., Lee, Jimmy, Falkai, Peter, Schneider-Axmann, Thomas and Hasan, Alkomiet (2020). Clozapine Combination and Augmentation Strategies in Patients with Schizophrenia - Recommendations from an International Expert Survey among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group. Schizophrenia Bulletin, 46 (6), 1459-1470. doi: 10.1093/schbul/sbaa060

Clozapine Combination and Augmentation Strategies in Patients with Schizophrenia - Recommendations from an International Expert Survey among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group

2020

Journal Article

CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis

Todorovic, Aleksandar, Lal, Sweta, Dark, Frances, De Monte, Veronica, Kisely, Steve and Siskind, Dan (2020). CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis. Journal of Mental Health, 32 (1), 1-8. doi: 10.1080/09638237.2020.1836558

CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis

2020

Journal Article

Quetiapine withdrawal: a systematic review

Monahan, Katherine, Cuzens-Sutton, Jaimie, Siskind, Dan and Kisely, Steve (2020). Quetiapine withdrawal: a systematic review. Australian and New Zealand Journal of Psychiatry, 55 (8) 0004867420965693, 000486742096569-783. doi: 10.1177/0004867420965693

Quetiapine withdrawal: a systematic review

2020

Journal Article

The association between lithium in drinking water and neuropsychiatric outcomes: a systematic review and meta-analysis from across 2678 regions containing 113 million

Eyre-Watt, Brenton, Mahendran, Eesharnan, Suetani, Shuichi, Firth, Joseph, Kisely, Steve and Siskind, Dan (2020). The association between lithium in drinking water and neuropsychiatric outcomes: a systematic review and meta-analysis from across 2678 regions containing 113 million. Australian and New Zealand Journal of Psychiatry, 55 (2), 139-152. doi: 10.1177/0004867420963740

The association between lithium in drinking water and neuropsychiatric outcomes: a systematic review and meta-analysis from across 2678 regions containing 113 million

2020

Journal Article

Phenelzine discontinuation: a bitter pill to swallow

Smith, Lesley and Siskind, Dan (2020). Phenelzine discontinuation: a bitter pill to swallow. Australian and New Zealand Journal of Psychiatry, 55 (8), 4867420965700-832. doi: 10.1177/0004867420965700

Phenelzine discontinuation: a bitter pill to swallow

2020

Conference Publication

Development and optimization of clozapine-loaded PLGA nanoparticles for nose-to-brain delivery using supercritical fluid technology

Tan, Madeleine S. A. , Parekh, Harendra S., Pandey, Preeti , Siskind, Dan J. and Falconer, James R. (2020). Development and optimization of clozapine-loaded PLGA nanoparticles for nose-to-brain delivery using supercritical fluid technology. 7th FIP Pharmaceutical Sciences World Congress, The Hague, Netherlands, 4-6 October 2020.

Development and optimization of clozapine-loaded PLGA nanoparticles for nose-to-brain delivery using supercritical fluid technology

2020

Journal Article

A meta-review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders

Firth, Joseph, Solmi, Marco, Wootton, Robyn E., Vancampfort, Davy, Schuch, Felipe B., Hoare, Erin, Gilbody, Simon, Torous, John, Teasdale, Scott B., Jackson, Sarah E., Smith, Lee, Eaton, Melissa, Jacka, Felice N., Veronese, Nicola, Marx, Wolfgang, Ashdown-Franks, Garcia, Siskind, Dan, Sarris, Jerome, Rosenbaum, Simon, Carvalho, André F. and Stubbs, Brendon (2020). A meta-review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry, 19 (3), 360-380. doi: 10.1002/wps.20773

A meta-review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders

2020

Journal Article

A systematic review and meta-analysis of predictors and outcomes of community treatment orders in Australia and New Zealand

Kisely, Steve, Yu, Dong, Maehashi, Saki and Siskind, Dan (2020). A systematic review and meta-analysis of predictors and outcomes of community treatment orders in Australia and New Zealand. Australian and New Zealand Journal of Psychiatry, 55 (7) 0004867420954286, 000486742095428-665. doi: 10.1177/0004867420954286

A systematic review and meta-analysis of predictors and outcomes of community treatment orders in Australia and New Zealand

2020

Journal Article

Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis

Siskind, Dan J., Wu, Brian T., Wong, Tommy T., Firth, Joseph and Kisely, Steve (2020). Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis. The Lancet Psychiatry, 7 (9), 762-774. doi: 10.1016/S2215-0366(20)30261-3

Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis

2020

Journal Article

Impact of smoking behavior on clozapine blood levels – a systematic review and meta‐analysis

Wagner, Elias, McMahon, Laura, Falkai, Peter, Hasan, Alkomiet and Siskind, Dan (2020). Impact of smoking behavior on clozapine blood levels – a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica, 142 (6) acps.13228, 456-466. doi: 10.1111/acps.13228

Impact of smoking behavior on clozapine blood levels – a systematic review and meta‐analysis

2020

Journal Article

Electroconvulsive therapy during severe acute respiratory syndrome coronavirus 2 pandemic

Warren, Nicola, Siskind, Dad and Lie, David (2020). Electroconvulsive therapy during severe acute respiratory syndrome coronavirus 2 pandemic. Australian and New Zealand Journal of Psychiatry, 54 (12), 4867420945777-1224. doi: 10.1177/0004867420945777

Electroconvulsive therapy during severe acute respiratory syndrome coronavirus 2 pandemic

2020

Journal Article

To the Editor

Siskind, Dan, Berk, Michael, Castle, David and Harris, Anthony (2020). To the Editor. Australian and New Zealand Journal of Psychiatry, 54 (7), 760-761.

To the Editor

2020

Journal Article

Clozapine and COVID-19: The authors respond

Siskind, Dan, Honer, William G., Clark, Scott, Correll, Christoph U., Hasan, Alkomiet, Howes, Oliver, Kane, John M., Kelly, Deanna L., Laitman, Robert, Lee, Jimmy, MacCabe, James H., Myles, Nick, Nielsen, Jimmi, Schulte, Peter F., Taylor, David, Verdoux, Helene, Wheeler, Amanda and Freudenreich, Oliver (2020). Clozapine and COVID-19: The authors respond. Journal of Psychiatry and Neuroscience, 45 (4), E1-E2. doi: 10.1503/jpn.2045302

Clozapine and COVID-19: The authors respond

2020

Journal Article

Screening for anti-NMDAR encephalitis in psychiatry

Warren, Nicola, Flavell, Joshua, O'Gorman, Cullen, Swayne, Andrew, Blum, Stefan, Kisely, Steve and Siskind, Dan (2020). Screening for anti-NMDAR encephalitis in psychiatry. Journal of Psychiatric Research, 125, 28-32. doi: 10.1016/j.jpsychires.2020.03.007

Screening for anti-NMDAR encephalitis in psychiatry

2020

Journal Article

Evaluation of the proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients

Warren, Nicola, O’Gorman, Cullen, Blum, Stefan, Kisely, Steve, Swayne, Andrew, Flavell, Joshua and Siskind, Dan (2020). Evaluation of the proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients. Acta Psychiatrica Scandinavica, 142 (1), 52-57. doi: 10.1111/acps.13197

Evaluation of the proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients

Funding

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Supervision

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au